|
humans |
11 |
|
male |
11 |
|
aged |
10 |
|
female |
10 |
|
middle aged |
10 |
|
carotid intima-media thickness |
9 |
|
25-hydroxyvitamin d |
7 |
|
arterial stiffness |
7 |
|
circulating endothelial progenitor cells |
7 |
|
cross-sectional studies |
7 |
|
endothelial progenitor cells |
7 |
|
pleiotropic effects |
7 |
|
statin therapy |
7 |
|
aging - immunology - metabolism |
6 |
|
ankle brachial index |
6 |
|
arterial calcification |
6 |
|
arthritis, rheumatoid - complications - immunology - physiopathology |
6 |
|
blood flow velocity |
6 |
|
brachial artery - physiopathology |
6 |
|
cardiovascular diseases - etiology |
6 |
|
confounding factors (epidemiology) |
6 |
|
coronary artery disease - epidemiology - immunology - physiopathology |
6 |
|
deficiency diseases - complications - physiopathology |
6 |
|
diet records |
6 |
|
endothelium, vascular - immunology - pathology |
6 |
|
energy intake |
6 |
|
mesenchymal stem cells - immunology - pathology |
6 |
|
nutrition |
6 |
|
nutrition assessment |
6 |
|
questionnaires |
6 |
|
rheumatoid arthritis |
6 |
|
secondary prevention |
6 |
|
selenium - administration & dosage - deficiency |
6 |
|
selenium deficiency |
6 |
|
trace elements - deficiency |
6 |
|
valvular heart disease |
6 |
|
vascular diseases - etiology - physiopathology |
6 |
|
vascular function |
6 |
|
adult |
5 |
|
atherosclerosis |
5 |
|
echocardiography |
5 |
|
estimated glomerular filtration rate |
5 |
|
heart failure |
5 |
|
outcome |
5 |
|
renal dysfunction |
5 |
|
retrospective studies |
5 |
|
acute kidney injury |
4 |
|
adipocyte fatty acid-binding protein |
4 |
|
aged, 80 and over |
4 |
|
amiodarone - adverse effects |
4 |
|
anti-arrhythmia agents - adverse effects |
4 |
|
article |
4 |
|
axial spondyloarthritis |
4 |
|
blood pressure |
4 |
|
body mass index |
4 |
|
bone marrow cells |
4 |
|
cardiac pacing, artificial - methods |
4 |
|
cardiovascular diseases - mortality |
4 |
|
chemicals and cas registry numbers |
4 |
|
community-acquired infections - epidemiology - microbiology |
4 |
|
congestive heart failure |
4 |
|
coronary artery disease |
4 |
|
coronary artery disease - physiopathology |
4 |
|
crt |
4 |
|
diabetes mellitus |
4 |
|
diabetes mellitus - physiopathology |
4 |
|
disease association |
4 |
|
doppler echocardiography |
4 |
|
echocardiography, doppler |
4 |
|
endocarditis, bacterial - epidemiology - microbiology |
4 |
|
endocarditis, bacterial - microbiology |
4 |
|
endothelial cells |
4 |
|
endothelial progenitor cell |
4 |
|
endothelium cell |
4 |
|
endothelium, vascular - physiopathology |
4 |
|
flow cytometry |
4 |
|
gram-positive bacterial infections |
4 |
|
health surveys |
4 |
|
heart failure - diagnosis - prevention & control |
4 |
|
heart right ventricle |
4 |
|
hong kong - epidemiology |
4 |
|
human |
4 |
|
hypercholesterolemia - physiopathology |
4 |
|
hypertension |
4 |
|
hypertension, pulmonary - diagnosis - prevention & control |
4 |
|
hypertension, pulmonary - physiopathology |
4 |
|
incidence |
4 |
|
infection |
4 |
|
infective endocarditis |
4 |
|
inflammation |
4 |
|
ischemic cardiomyopathy |
4 |
|
lactococcus |
4 |
|
left ventricular dysfunction |
4 |
|
left ventricular function |
4 |
|
lung artery pressure |
4 |
|
lung vascular resistance |
4 |
|
major clinical study |
4 |
|
multivariate analysis |
4 |
|
periodontal disease |
4 |
|
periodontitis |
4 |
|
priority journal |
4 |
|
pulmonary artery |
4 |
|
pulmonary hypertension |
4 |
|
rheumatic heart disease - epidemiology |
4 |
|
risk factors |
4 |
|
sleep apnea, central - diagnosis - prevention & control |
4 |
|
smoking |
4 |
|
smoking - adverse effects |
4 |
|
staphylococcus aureus |
4 |
|
stem cell |
4 |
|
stem cells |
4 |
|
substance abuse, intravenous - epidemiology |
4 |
|
systolic blood pressure |
4 |
|
thyrotoxicosis - chemically induced |
4 |
|
treatment outcome |
4 |
|
tricuspid annuloplasty |
4 |
|
type 2 diabetes |
4 |
|
vascular resistance |
4 |
|
ventricular function, left - drug effects |
4 |
|
atrial fibrillation |
3 |
|
atrial flutter - surgery |
3 |
|
atrioventricular block |
3 |
|
atrioventricular block - physiopathology - therapy |
3 |
|
cardiac pacing, artificial - adverse effects - methods |
3 |
|
catheter ablation - methods |
3 |
|
coronary angiography |
3 |
|
electrocardiography |
3 |
|
epidemiological characteristics |
3 |
|
follow-up studies |
3 |
|
heart failure - etiology - physiopathology - therapy |
3 |
|
microwaves - therapeutic use |
3 |
|
pacing |
3 |
|
pathogeny |
3 |
|
prevalence |
3 |
|
prevention |
3 |
|
psoriasis |
3 |
|
pulse wave velocity |
3 |
|
renin-angiotensin-aldosterone system |
3 |
|
right ventricular apex |
3 |
|
severity of illness index |
3 |
|
time factors |
3 |
|
tricuspid regurgitation |
3 |
|
ventricular function, left - physiology |
3 |
|
ventricular function, right - physiology |
3 |
|
algorithms |
2 |
|
aneurysm - etiology - radiography - ultrasonography |
2 |
|
angioplasty, balloon, coronary |
2 |
|
angiotensin ii type 1 receptor blockers - therapeutic use |
2 |
|
angiotensin-converting enzyme inhibitors - therapeutic use |
2 |
|
animals |
2 |
|
anti-arrhythmia agents - therapeutic use |
2 |
|
arrhythmias, cardiac - epidemiology - etiology - physiopathology - prevention & control |
2 |
|
arterio-arterial fistula - radiography - surgery |
2 |
|
aspirin - therapeutic use |
2 |
|
atherosclerosis - etiology - metabolism - therapy - ultrasonography |
2 |
|
autonomics |
2 |
|
bone marrow cells - physiology |
2 |
|
bone marrow transplantation - physiology |
2 |
|
calcium - analysis |
2 |
|
calcium channel blockers - therapeutic use |
2 |
|
cardiomyopathies - therapy |
2 |
|
cardiopulmonary resuscitation |
2 |
|
cardiotonic agents - adverse effects - diagnostic use |
2 |
|
cardiovascular diseases - pathology - physiopathology - psychology |
2 |
|
chi-square distribution |
2 |
|
chronic myocardial ischemia |
2 |
|
coronary artery bypass - adverse effects |
2 |
|
coronary artery disease (cad) |
2 |
|
coronary artery disease - pathology - therapy |
2 |
|
coronary occlusion - diagnosis |
2 |
|
coronary vasospasm - chemically induced - complications - physiopathology |
2 |
|
coronary vessels - pathology |
2 |
|
coronary vessels - surgery |
2 |
|
cytokines - therapeutic use |
2 |
|
death, sudden, cardiac - etiology |
2 |
|
depression |
2 |
|
depression - diagnosis |
2 |
|
drug therapy, combination |
2 |
|
dual coronary fistulas |
2 |
|
electrocardiography - methods |
2 |
|
endothelial cells - pathology - physiology |
2 |
|
endothelial function |
2 |
|
endothelial progenitor cells (epcs) |
2 |
|
endothelium, vascular - cytology - pathology - physiopathology |
2 |
|
fibrosis |
2 |
|
graft occlusion, vascular - etiology - metabolism - therapy - ultrasonography |
2 |
|
graft occlusion, vascular - etiology - radiography - ultrasonography |
2 |
|
granulocyte macrophage colony-stimulating factor |
2 |
|
hematopoietic stem cell mobilization |
2 |
|
hematopoietic stem cells (hscs) |
2 |
|
hemodynamics |
2 |
|
hypertension - complications - drug therapy |
2 |
|
hypertrophy, left ventricular - complications |
2 |
|
inferior wall myocardial infarction - diagnosis |
2 |
|
intravascular ultrasound |
2 |
|
isoproterenol - adverse effects - diagnostic use |
2 |
|
left to right heart shunt |
2 |
|
linear models |
2 |
|
lipids - analysis |
2 |
|
necrosis |
2 |
|
neovascularization, pathologic - therapy |
2 |
|
nitrates - therapeutic use |
2 |
|
predictive value of tests |
2 |
|
psychological tests |
2 |
|
pulmonary artery - radiography - surgery |
2 |
|
risk assessment |
2 |
|
saphenous vein - chemistry - transplantation - ultrasonography |
2 |
|
saphenous vein - radiography - transplantation - ultrasonography |
2 |
|
saphenous vein graft intervention |
2 |
|
sensitivity and specificity |
2 |
|
stem cells - pathology - physiology |
2 |
|
stem cells - physiology |
2 |
|
stress, psychological - diagnosis - psychology |
2 |
|
syncope - diagnosis |
2 |
|
tachycardia, ventricular - drug therapy - etiology |
2 |
|
tilt-table test - adverse effects - methods |
2 |
|
troponin i - blood |
2 |
|
ultrasonography, interventional |
2 |
|
vagal syndromes |
2 |
|
ventricular tachycardia |
2 |
|
virtual histology |
2 |
|
*ventricular remodeling |
1 |
|
cause of death |
1 |
|
comorbidity |
1 |
|
confidence intervals |
1 |
|
diabetes mellitus - epidemiology |
1 |
|
echocardiography/*methods |
1 |
|
heart failure - mortality - surgery - ultrasonography |
1 |
|
heart failure/physiopathology/*therapy/ultrasonography |
1 |
|
heart ventricles - surgery - ultrasonography |
1 |
|
heart ventricles/physiopathology/*ultrasonography |
1 |
|
hypertension - epidemiology |
1 |
|
length of stay |
1 |
|
myocardial ischemia - mortality - ultrasonography |
1 |
|
myocardial revascularization/*methods |
1 |
|
pulmonary disease, chronic obstructive - epidemiology |
1 |
|
stroke volume |
1 |
|
survival rate |
1 |
|
systole |
1 |
|
ventricular function, left/*physiology |
1 |
